ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ViiV’s Rukobia receives marketing authorisation in Europe for HIV treatment
February 10, 2021GlaxoSmithKline’s (GSK) ViiV Healthcare has announced the European Marketing Authorisation of its Rukobia (fostemsavir) 600mg extended-release tablets for use in combination with antiretroviral (ARV) therapies for treating adults with ... -
US FDA approves GSK’s HIV drug for patients with limited options
July 06, 2020The oral treatment from the company’s HIV unit, ViiV Healthcare, has been approved for adults whose HIV infection could not be successfully treated with other therapies due to resistance, intolerance or safety considerations. -
FDA approves ViiV's novel HIV treatment Rukobia
July 03, 2020The US Food and Drug Administration (FDA) has approved ViiV Healthcare's novel attachment inhibitor Rukobia (fostemsavir) expanding treatment options for HIV.
Pharma Sources Insight January 2025
